Due to a technical problem, exchange trading on gettex in the asset classes equities, bonds, funds & ETFs, in securities of the following market makers Baader Bank is currently interrupted.
Trading status
Status
de
Prices realtime
Indizes
UC DAX
UC MDAX
UC TECDAX
UC DJI
UC ESTOXX
UC NASQAD 100
Shares
ETFs & FUNDS
Bonds
Crypto
Screen markets
Stock screener
Certifcate Screener
ETF Screener
Fund Screener
Bond screener
Trading ideas
risk indices
risk indices
EU Intraday
EU Long Term
US Intraday
US Longterm
New on gettex
New listings stocks
New listings bonds
New intraday certificates
Blog
Newsletter
Watchlist
Support
Trading
Trading Calendar
Extended trading hours
Listing on demand
Announcements
Quality Reports
Delayed Data
Regulations
Become a Trade Participant
Cancellations
About Gettex
FAQs
Press
Partners
Committees
Career
Service & Contact
Why gettex
News overview
«
‹
…
2946
2947
2948
…
›
»
2026-04-06
The Competition Authority approved the acquisition of the full ownership of AS Õhtuleht Kirjastus by Ekspress Grupp
2026-04-06
Red Cat Expands Blue Ops Manufacturing Capabilities Though Strategic Partnership with HADDY
2026-04-06
EQS-News: DataBeyond Unveils Asia's Largest Unmanned AI Sorting Center, Setting a New Circular Economy Benchmark
2026-04-06
Epson RapidReceipt RR-600W Document Scanner Named a Good Housekeeping 2026 Cleaning Awards Winner
2026-04-06
KBR to Hold First Quarter Earnings Conference Call
2026-04-06
Copper Fox Metals Inc.: Copper Fox Announces 2026 Schaft Creek Program
2026-04-06
Newpath Resources Inc.: Newpath Resources Announces Termination of Northshore Option Agreement
2026-04-06
Simply Solventless Concentrates Ltd.: Simply Solventless Provides Restructuring Update, Including Expected Timing, and Announces Management Change
2026-04-06
Elevance Health Earnings Preview: What to Expect
2026-04-06
Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference
2026-04-06
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In Class Dual Inhibitor of KAT6/7 to Target Multiple Solid Tumor Indications, including Breast, Prostate, CRC, and Lung Cancer
2026-04-06
Radware Schedules Conference Call for Its First Quarter 2026 Earnings
«
‹
…
2946
2947
2948
…
›
»